Malcolm Hoffman
Stock Analyst at BMO Capital
(1.36)
# 3,680
Out of 4,639 analysts
6
Total ratings
60%
Success rate
-1.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Malcolm Hoffman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics | Maintained: Buy | $310 | $220.89 | +40.34% | 2 | Aug 10, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $36 | $29.39 | +22.49% | 2 | Aug 4, 2026 | |
| LBRX LB Pharmaceuticals | Initiated Coverage: Buy | $46 | $45.85 | +0.33% | 1 | Jul 21, 2026 | |
| MPLT MapLight Therapeutics | Initiated Coverage: Buy | $46 | $12.18 | +277.67% | 1 | Jul 21, 2026 |
Axsome Therapeutics
Aug 10, 2026
Maintained: Buy
Price Target: $310
Current: $220.89
Upside: +40.34%
ACADIA Pharmaceuticals
Aug 4, 2026
Maintained: Buy
Price Target: $36
Current: $29.39
Upside: +22.49%
LB Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $45.85
Upside: +0.33%
MapLight Therapeutics
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $12.18
Upside: +277.67%